Suppr超能文献

接受维持性血液透析患者的额外血液灌流:一项回顾性分析

Additional hemoperfusion for patients receiving maintenance hemodialysis: a retrospective analysis.

作者信息

Li Wendong, Wang Jing, Wang Yanqin, Guan Rui, Zhao Fan, Zhang Rongrong

机构信息

Department of Nephrology, Baoji People's Hospital Baoji 721000, Shaanxi, China.

Traditional Chinese Medicine Department, Baoji Maternal and Child Health Hospital Baoji 721000, Shaanxi, China.

出版信息

Am J Transl Res. 2023 Jun 15;15(6):4045-4054. eCollection 2023.

Abstract

OBJECTIVE

To determine the efficacy of hemodialysis combined with hemoperfusion with acupuncture on calcium-phosphorus metabolism disorder (CPMD) of patients who had received maintenance hemodialysis and its effect on intact parathyroid hormone (iPTH) and nutritional status.

METHODS

Data from 142 patients who were treated and given maintenance hemodialysis in Baoji People's Hospital from March 2018 to February 2020 were analyzed retrospectively. Patients treated with hemodialysis and acupuncture-moxibustion adjuvant therapy were enrolled into the control group (n=58), while those treated with hemoperfusion in addition to hemodialysis and acupuncture-moxibustion adjuvant therapy were enrolled into the research group (n=84). The two groups were compared in terms of changes in iPTH, calcium-phosphorus product, serum calcium (Ca), serum phosphorus (P), β2 microglobulin (β2-MG), serum albumin (Alb), creatinine (Scr) and urea nitrogen (BUN). The clinical efficacy in the two groups was compared after therapy, and the two groups were also compared in the improvement of immune function-related indexes (IgG and IgM) and the changes of nutrition-related indexes (Alb, prealbumin (PA) and hemoglobin (Hb)) before and after treatment. A risk prediction model was constructed based on LASSO regression to evaluate the predictive value of the risk score for efficacy of patients.

RESULTS

After treatment, the research group presented significantly lower levels of P, iPTH, and calcium-phosphorus product than the control group, but a significantly higher Ca level than the control group (all P<0.05). In addition, after treatment, the research group showed significantly lower levels of β2-MG, Scr and BUN but a higher Alb level than the control group (all P<0.05). After treatment, the research group had a greater improvement in immune function-related indexes (IgG and IgM) than the control group (all P<0.05), while the control group had significantly decreased Alb, PA and Hb after treatment (all P<0.05), but the levels of these in the research group did not change greatly (all P>0.05). Risk scoring formula was constructed: risk score = (dialysis time * 0.057123881) + (Ca * -0.100413548) + (P * 0.100419363) + (calcium and phosphorus product * 0.03872268) + (iPTH * 0.000358779). According to inter-group comparison of risk score, the Improvement group got a lower risk score than the Non-improvement group (P<0.0001). Moreover, according to ROC curve-based analysis, the area under the curve of risk score in predicting the efficacy of patients was 0.991.

CONCLUSION

Hemodialysis combined with acupuncture and blood perfusion can control the immune regulation by increasing the blood calcium content without affecting nutritional status, but it has no significant effect on the efficacy in patients.

摘要

目的

探讨血液透析联合血液灌流及针刺治疗对维持性血液透析患者钙磷代谢紊乱(CPMD)的疗效及其对全段甲状旁腺激素(iPTH)和营养状况的影响。

方法

回顾性分析2018年3月至2020年2月在宝鸡市人民医院接受维持性血液透析治疗的142例患者的资料。采用血液透析及针灸辅助治疗的患者纳入对照组(n = 58),采用血液灌流联合血液透析及针灸辅助治疗的患者纳入研究组(n = 84)。比较两组患者iPTH、钙磷乘积、血清钙(Ca)、血清磷(P)、β2微球蛋白(β2-MG)、血清白蛋白(Alb)、肌酐(Scr)和尿素氮(BUN)的变化。比较两组治疗后的临床疗效,以及两组治疗前后免疫功能相关指标(IgG和IgM)的改善情况和营养相关指标(Alb、前白蛋白(PA)和血红蛋白(Hb))的变化。基于LASSO回归构建风险预测模型,评估风险评分对患者疗效的预测价值。

结果

治疗后,研究组患者的P、iPTH及钙磷乘积水平显著低于对照组,但Ca水平显著高于对照组(均P < 0.05)。此外,治疗后,研究组患者的β2-MG、Scr和BUN水平显著低于对照组,但Alb水平高于对照组(均P < 0.05)。治疗后,研究组免疫功能相关指标(IgG和IgM)的改善程度大于对照组(均P < 0.05),而对照组治疗后Alb、PA和Hb水平显著下降(均P < 0.05),但研究组这些指标变化不大(均P > 0.05)。构建风险评分公式:风险评分 =(透析时间 * 0.057123881)+(Ca * -0.100413548)+(P * 0.100419363)+(钙磷乘积 * 0.03872268)+(iPTH * 0.000358779)。根据风险评分的组间比较,改善组的风险评分低于未改善组(P < 0.0001)。此外,根据基于ROC曲线的分析,风险评分预测患者疗效的曲线下面积为0.991。

结论

血液透析联合针刺及血液灌流可通过提高血钙含量控制免疫调节,且不影响营养状况,但对患者疗效无显著影响。

相似文献

3
Analysis of the parathyroid function in maintenance hemodialysis patients from Changchun, China.
Chronic Dis Transl Med. 2017 Aug 7;3(3):181-185. doi: 10.1016/j.cdtm.2017.07.001. eCollection 2017 Sep.
4
Effects of lanthanum carbonate on vascular calcification in elderly maintenance hemodialysis patients.
J Huazhong Univ Sci Technolog Med Sci. 2015 Aug;35(4):508-513. doi: 10.1007/s11596-015-1461-y. Epub 2015 Jul 31.
5
CD62P and P10 as predictive markers for assessing the efficacy of hemodialysis in treating end-stage renal disease.
J Clin Lab Anal. 2019 Feb;33(2):e22662. doi: 10.1002/jcla.22662. Epub 2018 Oct 15.
6
Determinants of the intensity of uremic pruritus in patients receiving maintenance hemodialysis: A cross-sectional study.
PLoS One. 2021 Jan 20;16(1):e0245370. doi: 10.1371/journal.pone.0245370. eCollection 2021.
7
Prevalence and determinants of parathyroid dysfunction in elderly patients on hemodialysis.
Blood Purif. 2014;37(2):119-24. doi: 10.1159/000357969. Epub 2014 Mar 20.

引用本文的文献

1
Serum Zn and Ca correlate with false positive non-invasive prenatal test results.
Am J Transl Res. 2025 Mar 15;17(3):2135-2144. doi: 10.62347/RBCP4815. eCollection 2025.

本文引用的文献

2
High serum β2-microglobulin is a significant predictor of mortality in maintenance hemodialysis patients.
Semin Dial. 2023 May-Jun;36(3):247-254. doi: 10.1111/sdi.13128. Epub 2022 Nov 13.
3
Polymethylmethacrylate Membrane Dialyzer: Historic but Modern.
Blood Purif. 2023;52 Suppl 1(Suppl 1):8-14. doi: 10.1159/000526996. Epub 2022 Oct 20.
4
Hemoperfusion in the intensive care unit.
Intensive Care Med. 2022 Oct;48(10):1397-1408. doi: 10.1007/s00134-022-06810-1. Epub 2022 Aug 19.
5
Hemoperfusion: technical aspects and state of the art.
Crit Care. 2022 May 12;26(1):135. doi: 10.1186/s13054-022-04009-w.
6
Clinical Profile of End Stage Renal Disease Patients Undergoing Hemodialysis in Chitwan, Nepal.
J Nepal Health Res Counc. 2021 Dec 10;19(3):467-473. doi: 10.33314/jnhrc.v19i3.3531.
7
[Nutrition and nutritional status of underweight patients].
Vopr Pitan. 2021;90(6):77-84. doi: 10.33029/0042-8833-2021-90-6-77-84. Epub 2021 Oct 26.
8
End-Stage Renal Disease: Medical Management.
Am Fam Physician. 2021 Nov 1;104(5):493-499.
9
Palliative Care in Patients with End-Stage Renal Disease: A Meta Synthesis.
Int J Environ Res Public Health. 2021 Oct 11;18(20):10651. doi: 10.3390/ijerph182010651.
10
Kidney Disease: End-Stage Renal Disease.
FP Essent. 2021 Oct;509:26-32.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验